Literature DB >> 18650986

Effect of moderately high dietary salt and lipoic acid on blood pressure in Wistar-Kyoto rats.

Sudesh Vasdev1, Vicki D Gill, Sushil Parai, Veeresh Gadag.   

Abstract

BACKGROUND: Approximately one-half of hypertensive individuals are salt sensitive, and animal models of human hypertension also exhibit increased blood pressure when exposed to high-salt diets. Salt sensitivity is associated with insulin resistance, which results in altered glucose metabolism, increasing aldehydes. Previously, the authors have shown that a high-salt diet (8% NaCl) caused an increase in blood pressure, tissue aldehyde conjugates and cytosolic free calcium, with resulting adverse renal vascular changes, in Wistar-Kyoto rats. Treatment with lipoic acid (LA) prevented an increase in blood pressure and attenuated biochemical and histopathological changes.
OBJECTIVES: The objective of the present study was to investigate the effect of a moderately high-salt (MHS) diet (4% NaCl) on these same parameters, and the modulating effect of LA in Wistar-Kyoto rats.
METHODS: At seven weeks of age, animals were divided into three groups. The normal-salt group was given a diet containing 0.7% NaCl; the MHS group was given a diet containing 4% NaCl; and the MHS+LA group was given a diet containing 4% NaCl plus LA (500 mg/kg diet) for 10 weeks.
RESULTS: At the end of the study, animals in the MHS group did not show any increase in systolic blood pressure, platelet cytosolic free calcium and tissue aldehyde conjugates. Furthermore, there were no adverse effects in renal vascular morphology compared with the normal salt group. In the MHS+LA group, LA did not lower blood pressure or affect other biochemical and histopathological parameters.
CONCLUSION: The present study suggests that moderately high sodium intake, over a short period, may not have any adverse effect and that LA does not lower blood pressure in normotensive rats.

Entities:  

Keywords:  Aldehydes; Blood pressure; Lipoic acid; Moderately high salt

Year:  2007        PMID: 18650986      PMCID: PMC2359601     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  50 in total

Review 1.  Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription.

Authors:  L Packer; S Roy; C K Sen
Journal:  Adv Pharmacol       Date:  1997

2.  Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production.

Authors:  Adil E L Midaoui; Aziz Elimadi; Lingyun Wu; Pierre S Haddad; Jacques de Champlain
Journal:  Am J Hypertens       Date:  2003-03       Impact factor: 2.689

Review 3.  Cellular insulin action and insulin resistance.

Authors:  W T Garvey; M J Birnbaum
Journal:  Baillieres Clin Endocrinol Metab       Date:  1993-10

4.  Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats.

Authors:  Sudesh Vasdev; Vicki Gill; Sushil Parai; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.

Authors:  S Jacob; P Ruus; R Hermann; H J Tritschler; E Maerker; W Renn; H J Augustin; G J Dietze; K Rett
Journal:  Free Radic Biol Med       Date:  1999-08       Impact factor: 7.376

6.  Definitions and characteristics of sodium sensitivity and blood pressure resistance.

Authors:  M H Weinberger; J Z Miller; F C Luft; C E Grim; N S Fineberg
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

Review 7.  Contribution of salt intake to insulin resistance associated with hypertension.

Authors:  Takehide Ogihara; Tomoichiro Asano; Toshiro Fujita
Journal:  Life Sci       Date:  2003-06-20       Impact factor: 5.037

8.  Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation.

Authors:  Sudesh Vasdev; Vicki Gill; Linda Longerich; Sushil Parai; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 9.  Salt sensitivity: concept and pathogenesis.

Authors:  O González-Albarrán; L M Ruilope; E Villa; R García Robles
Journal:  Diabetes Res Clin Pract       Date:  1998-04       Impact factor: 5.602

Review 10.  Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats.

Authors:  N Karachalias; R Babaei-Jadidi; N Ahmed; P J Thornalley
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  5 in total

1.  The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: a clinical trial.

Authors:  V Mohammadi; M Khalili; S Eghtesadi; S Dehghani; S Jazayeri; S K Aghababaee; H Sabour; H Saberi; M Eghtesadi; M R Gohari
Journal:  Spinal Cord       Date:  2015-03-10       Impact factor: 2.772

2.  MST3 (mammalian Ste20-like protein kinase 3), a novel gene involved in ion homeostasis and renal regulation of blood pressure in spontaneous hypertensive rats.

Authors:  Te-Jung Lu; Chee-Hong Chan; Pin Ling; Yung-Mei Chao; Bo-Ying Bao; Chun-Yen Chiang; Te-Hsiu Lee; Yui-Ping Weng; Wei-Chih Kan; Te-Ling Lu
Journal:  Int Urol Nephrol       Date:  2018-10-16       Impact factor: 2.370

Review 3.  Does Alpha-lipoic Acid Supplement Regulate Blood Pressure? A Systematic Review of Randomized, Double-blind Placebo-controlled Clinical Trials.

Authors:  Vida Mohammadi; Sirous Dehghani; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2017-05-11

4.  The effect of alpha-lipoic acid supplementation on anthropometric indices and food intake in patients who experienced stroke: A randomized, double-blind, placebo-controlled clinical trial.

Authors:  Vida Mohammadi; Fariborz Khorvash; Awat Feizi; Gholamreza Askari
Journal:  J Res Med Sci       Date:  2017-08-16       Impact factor: 1.852

5.  Does Alpha-lipoic Acid Supplementation Modulate Cardiovascular Risk Factors in Patients with Stroke? A Randomized, Double-blind Clinical Trial.

Authors:  Vida Mohammadi; Fariborz Khorvash; Awat Feizi; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2018-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.